Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML
Main Authors: | Benajiba, Lina, Alexe, Gabriela, Su, Angela, Raffoux, Emmanuel, Soulier, Jean, Hemann, Michael, Hermine, Olivier, Itzykson, Raphael, Stegmaier, Kimberly, Puissant, Alexandre |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2020
|
Online Access: | https://hdl.handle.net/1721.1/126001 |
Similar Items
-
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia
by: Bassil, Christopher F, et al.
Published: (2018) -
ERAD‐dependent control of the Wnt secretory factor Evi
by: Glaeser, K, et al.
Published: (2018) -
Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML
by: Matthieu Duchmann, et al.
Published: (2022-09-01) -
Creatine supplementation: effects on blood creatine kinase activity responses to resistance exercise and creatine kinase activity measurement
by: Marco Machado, et al.
Published: (2009-12-01) -
Creatine and creatine kinase in health and disease [electronic resource]: /
by: Salomons, Gajja S., et al.
Published: (2007)